Quality of Life and Its Determinants among Patients on Vitamin K Antagonist Therapy in India: A Baseline Cross- Sectional Analysis
Background: Vitamin K Antagonist (VKA) therapy has been extensively recommended for years to prevent thromboembolic disorders. The continued use of this treatment emphasizes its clinical importance across healthcare settings, particularly in resource-limited countries such as India. Chronic use of this therapy can impa...